RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
DI MAIO M
Collezione AO Ordine Mauriziano
Items : 227
Safety profile of darolutamide versus placebo: a systematic review and meta-analysis. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2024 Sep;27(3):385-392. doi: 10.1038/s41391-023-00775-y. Epub 2023 De
2024
ASL Asti
AO Ordine Mauriziano
Di Maio M; Tucci M; Vogl UM; Buttigliero C; Tombal B; Cathomas R; Smith MR; Fizazi K; Treglia G; Turco F; Gillessen S;
Withdrawal notice to
2024
AOU Città della Salute di Torino
AO Ordine Mauriziano
Russo P; Perrone F; Di Maio M; Cavanna L; Cinieri S; Blasi L; Pinto C; Beretta GD; Piccirillo MC; Sferrazza A; Di Segni S; Olimpieri PP; Salerno F; Canciello A; Arenare L; Caglio A; Tomassini L; Iacovino ML; Celant S;
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Oct;22(5):102138. doi: 10.1016/j.clgc.2024.102138. Epub 2024 Jun 12.
2024
ASL Asti
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Tucci M; Scagliotti GV; Di Maio M; Palesandro E; Poletto S; Calabrese M; Saporita I; Crespi V; Farinea G; Di Stefano RF; Gallina A; Fossati N; Zilli T; Delcuratolo MD; Gillessen S; Turco F; Vogl UM; Buttigliero C;
Re: Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.08.007. in European urology focus / Eur Urol Focus. 2024 May;10(3):497. doi: 10.1016/j.euf.2023.01.024. Epub 2023 Feb 20.
2024
AO Ordine Mauriziano
Di Maio M; Montorsi F; Necchi A; Marandino L; Raggi D; Gandaglia G; Briganti A;
Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effects. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2024 Mar 1;32(3):202. doi: 10.1007/s00520-024-08392-8.
2024
ASL Asti
AOU Alessandria
AO Ordine Mauriziano
Cinieri S; Comandone A; Airoldi M; Rossi M; Rossetti G; Lanzetta G; Cavanna L; Bossi P; Ibrahim T; De Giorgi U; Tucci M; Santini D; Fusco V; Di Maio M; Valsecchi AA;
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System. in JCO oncology practice / JCO Oncol Pract. 2024 Mar;20(3):438-447. doi: 10.1200/OP.23.00434. Epub 2024 Jan 11.
2024
AOU Novara
AO Ordine Mauriziano
Efficace F; Vignetti M; Fazi P; Luppi M; Platzbecker U; Baron F; Di Maio M; Venditti A; Perrone F; Voso MT; Brini A; Cavo M; Gaidano G; Anota A; Giesinger JM; Sparano F;
Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey. in Tumori / Tumori. 2024 Jun;110(3):174-185. doi: 10.1177/03008916241236279. Epub 2024 Mar 10.
2024
ASL Asti
AOU Alessandria
AO Ordine Mauriziano
Cinieri S; Vignani F; Valsecchi AA; Fusco V; Dionisio R; De Giorgi U; Di Maio M; Santini D; Tucci M;
Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study. in The Lancet regional health. Europe / Lancet Reg Health Eur. 2024 Apr 22;41:100912. doi: 10.1016/j.lanepe.2024.100912. eCollection 2024 Ju
2024
AOU Città della Salute di Torino
AO Ordine Mauriziano
Iacovino ML; Celant S; Tomassini L; Arenare L; Caglio A; Canciello A; Salerno F; Olimpieri PP; Di Segni S; Sferrazza A; Piccirillo MC; Beretta GD; Pinto C; Blasi L; Cinieri S; Cavanna L; Perrone F; Russo P; Di Maio M;
Intravenous antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention : A report from the INVEST-STEMI group. in Journal of thrombosis and thrombolysis / J Thromb Thrombolysis. 2024 Jun;57(5):757-766. doi: 10.1007/s11239-024-02970-7. Epub 2024 Apr 13.
2024
AO Ordine Mauriziano
Scudiero F; Attisano T; Baldi C; Catalano A; Centore M; Cesaro A; Di Maio M; Esposito L; Granata G; Maiellaro F; Muraca I; Galasso G; Calabrò P; Silverio A; Vecchione C; Valenti R; Personeni D; Parodi G; Musumeci G; Bellino M;
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]. in The Lancet regional health. Europe / Lancet Reg Health Eur. 2024 May 21;42:100940. doi: 10.1016/j.lanepe.2024.100940. eCollection 2024 Ju
2024
AOU Città della Salute di Torino
AO Ordine Mauriziano
Russo P; Perrone F; Cavanna L; Di Maio M; Cinieri S; Blasi L; Piccirillo MC; Pinto C; Beretta GD; Sferrazza A; Di Segni S; Olimpieri PP; Canciello A; Salerno F; Caglio A; Celant S; Tomassini L; Arenare L; Iacovino ML;
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]. in The Lancet regional health. Europe / Lancet Reg Health Eur. 2024 Jun 24;42:100973. doi: 10.1016/j.lanepe.2024.100973. eCollection 2024 Ju
2024
AOU Città della Salute di Torino
AO Ordine Mauriziano
Perrone F; Di Maio M; Russo P; Cavanna L; Cinieri S; Blasi L; Pinto C; Piccirillo MC; Domenico Beretta G; Sferrazza A; Di Segni S; Salerno F; Olimpieri PP; Caglio A; Canciello A; Tomassini L; Arenare L; Iacovino ML; Celant S;
Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2024 Jan;19(1):166-172. doi: 10.1016/j.jtho.2023.08.004. Epub 2023 Aug 9.
2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Di Maio M; Remon J; Bironzo P; Genova C; Facchinetti F; Aldea M; Le Péchoux C; Novello S; Barlesi F; Besse B; Planchard D; Tagliamento M;
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology. in Tumori / Tumori. 2024 Feb;110(1):60-68. doi: 10.1177/03008916231191547. Epub 2023 Aug 10.
2024
AO Ordine Mauriziano
Cinieri S; Pedrazzoli P; Di Maio M; Silvestris N; Lasagna A; Brunello A;
The relationship among posttraumatic stress disorder, posttraumatic growth, and suicidal ideation among Italian healthcare workers during the first wave of COVID-19 pandemic. in CNS spectrums / CNS Spectr. 2024 Feb;29(1):60-64. doi: 10.1017/S1092852923002493. Epub 2023 Sep 27.
2024
AO Ordine Mauriziano
Di Maio M; Cirnigliaro G; Loupakis F; Cerioli M; Boscacci M; Achilli F; Cafaro R; Gesi C; Dell'Osso B;
Association between health-related quality-of-life results, outcomes of efficacy and drug approvals: a meta-research study of randomized phase III trials in oncology. in ESMO open / ESMO Open. 2024 Aug;9(8):103654. doi: 10.1016/j.esmoop.2024.103654. Epub 2024 Jul 26.
2024
ASL Torino 4
AOU Città della Salute di Torino
AO Ordine Mauriziano
Di Maio M; Marandino L; Vellani G; Paratore C; Zichi C; Schiavone R; Bombaci S; Gamba T; Perrone F; Caglio A;
A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia. in EMBO reports / EMBO Rep. 2024 Apr;25(4):1886-1908. doi: 10.1038/s44319-024-00104-x. Epub 2024 Feb 27.
2024
AOU Città della Salute di Torino
AO Ordine Mauriziano
Bussolino F; Arese M; Cappello P; Scarpa A; Lawlor R; Di Maio M; Novelli F; Parab S; Allavena P; Cristiano C; Papotti M; Hoza RM; Metovic J; Spadi R; Vallariello E; Astanina E; Middonti E;
Which patients should receive electronic patient-reported outcome measures in clinical practice? in Cancer / Cancer. 2023 Sep 15;129(18):2915-2916. doi: 10.1002/cncr.34954. Epub 2023 Jul 11.
2023
AO Ordine Mauriziano
Di Maio M;
Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial. in International journal of cancer / Int J Cancer. 2023 Oct 15;153(8):1520-1528. doi: 10.1002/ijc.34632. Epub 2023 Jun 30.
2023
AO Ordine Mauriziano
Troiani T; Ciardiello F; Marrone F; Altucci L; De Vita F; Del Tufo S; Di Maio M; Zampino MG; Fazio N; Montesarchio V; De Stefano A; Cardone C; Di Liello A; Avallone A; Famiglietti V; Esposito L; Martinelli E; Della Corte CM; Martini G; De Falco V; Ciardiello D; Napolitano S;
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society. in Tumori / Tumori. 2023 Oct;109(5):490-495. doi: 10.1177/03008916221146820. Epub 2023 Jan 6.
2023
ASL Torino 5
AO Ordine Mauriziano
Artioli G; Valabrega G; Purro A; Milani A; Scotto G; Turinetto M; Bellero M; Mammoliti S; Testa S; Mangili G; Di Maio M; Savarese A; Biglia N; Lorusso D; Scandurra G; Castaldo D; De Giorgi U; Pignata S; Tuninetti V;
Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial Cancer. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2023 Oct;21(5):509-516. doi: 10.1016/j.clgc.2023.07.009. Epub 2023 Jul 20.
2023
AO Ordine Mauriziano
Vignani F; Dionisio R; Di Maio M; Paparo J; Panepinto O; Gamba T;
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis. in iScience / iScience. 2023 Sep 22;26(11):107970. doi: 10.1016/j.isci.2023.107970. eCollection 2023 Nov 17.
2023
AO Ordine Mauriziano
AOU Alessandria
Bersanelli M; Banna GL; Addeo A; Rescigno P; Fornarini G; Rebuzzi SE; Buti S; Pinto C; Di Maio M; De Giorgi U; Russo A; Giannarelli D; Pignata S; Cosenza A; Vignani F; Ricciardi S; Zucali PA; Sorarù M; Camerini A; Banzi MC; Cinieri S; Tondini CA; Accettura C; Fratino L; Mencoboni M; Zustovich F; Verderame F; Rizzo M; Montesarchio V; et alii...
Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations. in EClinicalMedicine / EClinicalMedicine. 2023 Oct 17;65:102277. doi: 10.1016/j.eclinm.2023.102277. eCollection 2023 Nov.
2023
AO Ordine Mauriziano
Cinieri S; Perrone F; Beretta GD; Carieri E; Converti M; Di Maio M; Iula B; Lambertini M; Berardi R; Marsoni S; Dalu D; La Verde N; Morano F; Massagrande M; Trapani D; Miceli R; Casolino R; Leone AG; Pietrantonio F;
Preexisting evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review. in Journal of the National Cancer Institute / J Natl Cancer Inst. 2023 May 8;115(5):505-513. doi: 10.1093/jnci/djad030.
2023
AO Ordine Mauriziano
Sclafani F; Hendlisz A; Di Maio M; Assaf I; Akin Telli T; Vanhooren M; Trevisi E; Saúde Conde R; Bregni G;
Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trial. in Gynecologic oncology / Gynecol Oncol. 2023 May;172:121-129. doi: 10.1016/j.ygyno.2023.03.019. Epub 2023 Apr 6.
2023
AO Ordine Mauriziano
Pignata S; Oza A; Hall G; Pardo B; Madry R; Cibula D; Klat J; Montes A; Glasspool R; Colombo N; Pete I; Herrero Ibáñez A; Marín MR; Ilieva R; Timcheva C; Di Maio M; Blakeley C; Taylor R; Barnicle A; Clamp A;
The Value of Patient-Reported Outcomes in Single-Arm Cancer Trials. in Cancer investigation / Cancer Invest. 2023 May;41(5):491-494. doi: 10.1080/07357907.2023.2206497. Epub 2023 May 2.
2023
AO Ordine Mauriziano
Di Maio M;
Real-world retrospective study of KRAS mutations in advanced non-small cell lung cancer in the era of immunotherapy. in Cancer / Cancer. 2023 Jun 1;129(11):1662-1671. doi: 10.1002/cncr.34731. Epub 2023 Mar 11.
2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Bironzo P; Scagliotti GV; Righi L; Novello S; Di Maio M; Passiglia F; Listì A; Napoli VM; Jacobs F; Cani M;
Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology. in ESMO open / ESMO Open. 2023 Jun;8(3):101578. doi: 10.1016/j.esmoop.2023.101578. Epub 2023 Jun 2.
2023
AO Ordine Mauriziano
Pietrantonio F; Di Maio M; Beretta GD; Perrone F; Cinieri S; Dalu D; Lambertini M; Berardi R; Casolino R; Marsoni S; La Verde N; Trapani D; Massagrande M; Morano F; Leone AG; Miceli R;
Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM). in ESMO open / ESMO Open. 2023 Jun;8(3):101215. doi: 10.1016/j.esmoop.2023.101215. Epub 2023 Apr 3.
2023
AO Ordine Mauriziano
Cinieri S; Silvestris N; Beretta GD; Piralla A; Squeri A; Bruno R; Di Maio M; Sacchi P; Cassaniti I; Pedrazzoli P; Baldanti F; Lasagna A;
Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes. in BMC medicine / BMC Med. 2023 Jul 3;21(1):234. doi: 10.1186/s12916-023-02953-0.
2023
AO Ordine Mauriziano
ASL Torino 4
Bianco R; Salomone F; Formisano L; Santaniello A; Viscardi G; Di Costanzo F; Servetto A; Paratore C; Napolitano F; Di Maio M;
Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience. in Cancers / Cancers (Basel). 2023 Jul 15;15(14):3639. doi: 10.3390/cancers15143639.
2023
AO Cuneo
AO Ordine Mauriziano
Valabrega G; Turinetto M; Di Maio M; Scotto G; Caglio A; Rognone C; Puppo A; Pezua Sanjinez JOS; Jacomuzzi E; Fuso L; Gallo S; Ferrero A; Cormio G; Biglia N; Borsotti L; Geuna E; Mandato VD; Arezzo F; Palicelli A; Quarà V; Pace L; Ghisoni E; Tuninetti V;
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. in JAMA oncology / JAMA Oncol. 2023 Jul 1;9(7):966-970. doi: 10.1001/jamaoncol.2023.0655.
2023
AO Ordine Mauriziano
Ciardiello F; Troiani T; Di Maio M; De Vita F; Altucci L; Marrone F; Santini D; Scartozzi M; Zampino MG; Bordonaro R; Montesarchio V; De Stefano A; Cardone C; Avallone A; Di Liello A; Famiglietti V; Esposito L; Della Corte CM; Ciardiello D; Martinelli E; Martini G; De Falco V; Napolitano S;
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study. in EClinicalMedicine / EClinicalMedicine. 2023 Jun 29;61:102044. doi: 10.1016/j.eclinm.2023.102044. eCollection 2023 Jul.
2023
AO Ordine Mauriziano
AOU Alessandria
Buti S; Di Maio M; Pignata S; Clemente A; Tognetto M; De Giorgi U; Pinto C; Labianca R; Maiello E; Santini D; Nanni O; Luzi Fedeli S; Giovanis P; Beretta G; Ceribelli A; Silva RR; Nolè F; Spada M; Bordonaro R; Morelli MF; Tagliaferri P; Iannopollo M; Sartori D; Guida M; Baldini E; Longo L; Bonetti A; Mucciarini C; Santoni M; et alii...
Trastuzumab deruxtecan for breast cancer: do patients experience a comprehensive benefit? in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2023 Jul;34(7):567-568. doi: 10.1016/j.annonc.2023.05.011.
2023
AO Ordine Mauriziano
Mosele F; Di Maio M;
Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center Experience. in Biomedicines / Biomedicines. 2023 Jan 9;11(1):165. doi: 10.3390/biomedicines11010165.
2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Novello S; Passiglia F; Scagliotti GV; D'Amiano C; Gianetta M; Di Maio M; Capelletto E; Bianco V; Napoli VM; Leone G; Turco F; Audisio A; Cecchi C; Delcuratolo MD; Cetoretta V; Parlagreco E; Pisano C; Garbo E; Ferrari G; Bironzo P; Persano I; Del Rio B; Cani M; Bertaglia V;
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial. in European urology / Eur Urol. 2023 Jan;83(1):82-89. doi: 10.1016/j.eururo.2022.09.025. Epub 2022 Oct 8.
2023
AO Ordine Mauriziano
Santini D; Pierantoni F; Zonno A; Lolli C; Procopio G; Di Napoli M; Ignazzi G; Pignata S; Veccia A; Scandurra G; Gamba T; Ermacora P; Aieta M; Masini C; Hamzaj A; Atzori F; Stellato M; Carella C; Giannatempo P; Bimbatti D; De Giorgi U; Tambaro R; Vignani F; Di Maio M;
Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Jan;181:103881. doi: 10.1016/j.critrevonc.2022.103881. Epub 2022 Nov 24
2023
AO Ordine Mauriziano
ASL Asti
AOU San Luigi di Orbassano
Scagliotti GV; Buttigliero C; Di Maio M; Audisio A; Brusa F; Ungaro A; Audisio M; Samuelly A; Turco F; Di Stefano RF; Tucci M; Delcuratolo MD;
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study. in Cancers / Cancers (Basel). 2023 Feb 6;15(4):1032. doi: 10.3390/cancers15041032.
2023
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
Valabrega G; Di Maio M; Sangiolo D; Scotto G; Turinetto M; Borsotti L; Paolini B; Puppo A; Marinaccio M; Carella C; Cormio G; Parisi A; Mandato VD; Biglia N; Zanchi L; Sikokis A; Mammoliti S; Artioli G; Maldi E; Andreetta C; Raspagliesi F; Picardo E; Ghisoni E; Pignata S; Tuninetti V;
Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors. in JAMA network open / JAMA Netw Open. 2023 Feb 1;6(2):e230490. doi: 10.1001/jamanetworkopen.2023.0490.
2023
AO Ordine Mauriziano
Zer A; Rosenbaum E; Hall PS; Perrone F; Di Maio M; Goh BC; Chan KKW; Loong HH; De Abreu Lourenco R; Hofnung-Gabbay D; Ginsberg GM; Goldstein DA;
Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysis. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Feb;180:117-124. doi: 10.1016/j.ejca.2022.12.005. Epub 2022 Dec 12.
2023
AO Ordine Mauriziano
Besse B; Hochstenbag M; Hendriks LEL; Marcuse F; Tiseo M; Remon J; Facchinetti F; Di Maio M; Villacampa G;
Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study. in Breast (Edinburgh, Scotland) / Breast. 2023 Dec;72:103583. doi: 10.1016/j.breast.2023.103583. Epub 2023 Sep 25.
2023
AO Ordine Mauriziano
Del Mastro L; Puglisi F; Riccardi F; Picotto C; De Laurentiis M; De Placido P; Giuliano M; De Angelis C; Fabi A; Ruelle T; Marandino L; Schettini F; Arpino G; Di Maio M; Bighin C;
Clinical value of offering multiple chemotherapy lines to a luminal-like metastatic breast cancer: A case report with eribulin. in Tumori / Tumori. 2023 Dec;109(6):NP1-NP5. doi: 10.1177/03008916221141929. Epub 2022 Dec 8.
2023
AO Ordine Mauriziano
Dionisio R; Di Maio M; Pirro V; Manfredi M; Valsecchi AA; Paparo J;
Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients. in ESMO open / ESMO Open. 2023 Dec;8(6):102192. doi: 10.1016/j.esmoop.2023.102192. Epub 2023 Dec 5.
2023
AO Ordine Mauriziano
Frontini L; Giannarelli D; Arenare L; Porta C; Barberio D; Terzolo S; Zagonel V; Pisconti S; Del Mastro L; Gallo C; Di Maio M; Riva S; Efficace F; Jommi C; Piccirillo MC; Bryce J; Vaccaro MC; Gitto L; Traclò F; Iannelli E; De Lorenzo F; Del Campo L; Montesarchio V; Migliaccio G; Rizzo M; Cinieri S; Bilancia D; Pinto C; Perrone F; et alii...
Systematic review of adoption, reporting and impact of health-related quality of life in phase III non-inferiority trials of systemic oncology treatments. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Dec;195:113374. doi: 10.1016/j.ejca.2023.113374. Epub 2023 Oct 22.
2023
AO Ordine Mauriziano
Di Maio M; Perrone F; Marandino L; Paparo J; Notarnicola S; Zumstein L;
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Aug;189:112920. doi: 10.1016/j.ejca.2023.05.008. Epub 2023 May 15.
2023
AO Cuneo
ASL Cuneo 2
AO Ordine Mauriziano
ASL Torino 4
AOU San Luigi di Orbassano
Tuninetti V; Turco F; Fabi A; Perrone F; Di Maio M; Reale ML; Trastu F; Paratore C; Marandino L; Mariniello A; Lombardi P; Ghisoni E; Bungaro M; Caglio A; Di Liello R; Gamba T; Gargiulo P; Rossi A; Aimar G; Audisio M;
Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis. in Cancers / Cancers (Basel). 2023 Apr 24;15(9):2435. doi: 10.3390/cancers15092435.
2023
AO Ordine Mauriziano
Di Maio M; Vignani F; Palicelli A; Paparo J; Dionisio R; Panepinto O; Valsecchi AA;
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis. in Tumori / Tumori. 2023 Apr;109(2):233-243. doi: 10.1177/03008916221077144. Epub 2022 Mar 31.
2023
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Buttigliero C; Di Maio M; Scagliotti GV; Ungaro A; Parlagreco E; Audisio A; Audisio M; Angusti T; Parente A; Di Stefano RF; Urban S; Pisano C; Samuelly A; Tucci M; Turco F;
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors. in Frontiers in oncology / Front Oncol. 2023 Sep 14;13:1247291. doi: 10.3389/fonc.2023.1247291. eCollection 2023.
2023
AO Ordine Mauriziano
Mangili G; Artioli G; Mammoliti S; Bartoletti M; Arezzo F; Tuninetti V; Scotto G; Giannone G; Castaldo D; Turinetto M; Salutari V; Lorusso D; Cormio G; Loizzi V; Zamagni C; Savarese A; Di Maio M; Ronzino G; Pisano C; Pignata S; Valabrega G;
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Sep;33(9):878-892. doi: 10.1016/j.annonc.2022.04.007. Epub 2022 Apr 21.
2022
AO Ordine Mauriziano
Santini D; Ripamonti CI; Freeman-Daily J; Apostolidis K; Zhang L; Warrington L; Sundaresan P; Stover AM; Perrone F; Howell D; Kowalski C; Ganz PA; Denis F; Fallowfield LJ; Di Maio M; Basch E;
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer. in Cells / Cells. 2022 Oct 14;11(20):3226. doi: 10.3390/cells11203226.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Geuna M; Bironzo P; Passiglia F; Righi L; Sangiolo D; Novello S; Paratore C; Di Maio M; De Filippis M; Bungaro M; Bertaglia V; Mecca C; Consito L; Carnio S; Capelletto E; Listì A; Reale ML; Rezmives NA; Tesauro M; Indellicati D; Tabbò F; Mariniello A;
Efficacy and safety of PARP inhibitors in elderly patients with advanced ovarian cancer: a systematic review and meta-analysis. in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society / Int J Gynecol Cancer. 2022 Oct 13;32(11):1410-8. doi: 10.1136/ijgc-2022-003614.
2022
AO Ordine Mauriziano
Maiello E; Di Maio M; Lorusso D; Maiorano MFP; Maiorano BA;
Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Oct;174:200-211. doi: 10.1016/j.ejca.2022.07.026. Epub 2022 Aug 28.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Righi L; Novello S; Graziano P; Scagliotti GV; Bria E; Volante M; Rossi A; Rossi G; Osman G; Di Maio M; Bareggi C; Del Conte A; Cappuzzo F; Cortinovis D; Pilotto S; Gregorc V; Sergi C; Ghilardi L; Scotti V; Martelli O; Tiseo M; Galetta D; Maiello E; Rigutto A; Castellana S; Trombetta D; Gobbini E; Tabbò F; Muscarella LA; et alii...
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM). in ESMO open / ESMO Open. 2022 Oct;7(5):100567. doi: 10.1016/j.esmoop.2022.100567. Epub 2022 Aug 19.
2022
AO Ordine Mauriziano
Maiello E; Tamburini E; Maiorano BA; Parrella P; Latiano TP; Normanno N; De Vita F; Ciardiello F; Martinelli E; Troiani T; Napolitano S; Martini G; Avallone A; De Stefano A; Damato A; Pinto C; Zampino MG; Castellano G; Gervaso L; Antonuzzo L; Lavacchi D; Berardi R; Giampieri R; Di Maio M; Parisi A; Zichi C; De Vita F; Bordonaro R; Rapisardi S; et alii...
Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis. in ESMO open / ESMO Open. 2022 Oct;7(5):100575. doi: 10.1016/j.esmoop.2022.100575. Epub 2022 Sep 22.
2022
AO Ordine Mauriziano
AOU Novara
Di Maio M; Cattrini C; Altavilla A; Messina C; Roviello G; De Giorgi U; Maiorano BA; Maiello E; Mennitto A;
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial. in International journal of cancer / Int J Cancer. 2022 Nov 15;151(10):1760-1769. doi: 10.1002/ijc.34156. Epub 2022 Jun 23.
2022
ASL Torino 4
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Morano F; Pietrantonio F; Di Maio M; Di Bartolomeo M; Antonuzzo L; Giordano M; Rossi A; Ratti M; Petrelli F; Berenato R; Clavarezza M; Zaniboni A; Fanchini L; Murialdo R; Sartore-Bianchi A; Tampellini M; Bozzarelli S; Antoniotti C; Lonardi S; Pagani F; Prisciandaro M; Randon G; Raimondi A;
MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis. in Cancer treatment reviews / Cancer Treat Rev. 2022 Nov;110:102458. doi: 10.1016/j.ctrv.2022.102458. Epub 2022 Aug 24.
2022
AO Ordine Mauriziano
Di Maio M; Lorusso D; Scambia G; Fagotti A; Pignata S; Marchetti C; Bartoletti M; Giannone G; Tuninetti V; Camarda F; Valabrega G; Valsecchi AA; Salutari V; Musacchio L;
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O(6)-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 May 10;40(14):1562-1573. doi: 10.1200/JCO.21.02583. Epub 2022 Mar 8.
2022
AOU Città della Salute di Torino
AO Ordine Mauriziano
Milione M; Di Bartolomeo M; de Braud F; Pietrantonio F; Di Maio M; Perrone F; Tamborini E; Brich S; Busico A; Conca E; Capone I; Marmorino F; Calegari MA; Cagnazzo C; Ratti M; Palazzo M; Corti F; Bergamo F; Zaniboni A; Niger M; Prisciandaro M; Racca P; Pella N; Antonuzzo L; Palermo F; Randon G; Murgioni S; Lonardi S; Salvatore L; et alii...
Impact of Blinding on Patient-Reported Outcome Differences Between Treatment Arms in Cancer Randomized Controlled Trials. in Journal of the National Cancer Institute / J Natl Cancer Inst. 2022 Mar 8;114(3):471-474. doi: 10.1093/jnci/djab177.
2022
AO Ordine Mauriziano
Giesinger JM; Vignetti M; Gamper EM; Sparano F; Perrone F; Cottone F; Di Maio M; Calvert M; Aaronson NK; Efficace F; Cella D;
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index. in Journal of gastrointestinal cancer / J Gastrointest Cancer. 2022 Jun;53(2):289-298. doi: 10.1007/s12029-021-00596-z. Epub 2021 Feb 5.
2022
ASL Biella
AO Ordine Mauriziano
AOU Città della Salute di Torino
Casadei-Gardini A; Cascinu S; Orsi G; Aprile G; Di Maio M; Jeong JH; de Braud F; Vasile E; De Lorenzo S; Pella N; Fenocchio E; Nichetti F; Lai E; Cho H; Vivaldi C; Aglietta M; Faloppi L; Palloni A; Santini D; Silvestris N; Casagrande M; Filippi R; Scartozzi M; Niger M; Yoo C; Caputo F; Fornaro L; Brandi G; Rovesti G; et alii...
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11
2022
ASL Asti
ASL Torino 4
ASL Cuneo 1
ASL Cuneo 2
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Buttigliero C; Scagliotti GV; Di Maio M; Ortega C; Di Prima L; Audisio A; Turco F; Ungaro A; Parlagreco E; Di Stefano RF; Audisio M; Tucci M;
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies. in ESMO open / ESMO Open. 2022 Jun;7(3):100459. doi: 10.1016/j.esmoop.2022.100459. Epub 2022 May 19.
2022
AO Ordine Mauriziano
Sapino A; Jereczek-Fossa BA; Luchini C; Lapini A; Del Re M; Dessena M; Barberis M; Turchetti D; Di Maio M; De Giorgi U; Genuardi M; Gori S; Cortesi L; Capoluongo E; Tagliaferri P; Russo A; Incorvaia L; Cinieri S;
Impact of Novel Hormonal Therapy on Cognitive Function: Essential to Measure, Difficult to Present. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Jul 1;40(19):2174-2175. doi: 10.1200/JCO.22.00092. Epub 2022 Apr 21.
2022
AO Ordine Mauriziano
Di Maio M; Necchi A; Marandino L; Raggi D;
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.
2022
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara
Pinato DJ; Russo A; Russano M; Porzio G; Tiseo M; Ficorella C; Addeo A; Banna GL; Friedlaender A; Metro G; Spinelli GP; Passiglia F; Migliorino MR; Ricciardi S; Pecci F; Zoratto F; De Tursi M; Di Marino P; Mansueto G; Tuzi A; Gori S; Della Gravara L; Rastelli F; Chiari R; Macerelli M; Marchetti P; Gelibter A; Antonuzzo L; Berardi R; et alii...
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2022 Jan;22(1):115-121. doi: 10.1080/14737140.2022.2002688. Epub 2021 No
2022
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Pignata S; De Braud FG; Verzoni E; Procopio G; Ottini A; Guadalupi V; Claps M; Sepe P; Buttigliero C; Stellato M; Roviello G; Di Lorenzo G; Mucciarini C; Messina C; Santini D; Casadei C; Sorarù M; Buti S; De Giorgi U; Bimbatti D; Di Maio M; Zattarin E; Mennitto A;
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside. in Cells / Cells. 2022 Feb 25;11(5):803. doi: 10.3390/cells11050803.
2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Delcuratolo MD; Ungaro A; Buttigliero C; Di Maio M; Audisio A; Di Prima L; Turco F; Scagliotti GV; Pisano C; Tucci M;
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors. in JAMA network open / JAMA Netw Open. 2022 Feb 1;5(2):e220290. doi: 10.1001/jamanetworkopen.2022.0290.
2022
ASL Torino 4
ASL Città di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Spada F; Andreasi V; Di Bartolomeo M; Casadei R; Coppa J; Milione M; Sabella G; Modica R; Scalorbi F; Falconi M; Severi S; Zanata I; Bracigliano A; Puliafito I; Ambrosio MR; Lamberti G; Cingarlini S; Rinzivillo M; Pignata SA; Rocca PA; Persano I; Versari A; Bongiovanni A; Seregni E; Maccauro M; Lastoria S; Di Maio M; Porcu L; Giacomelli L; et alii...
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations. in Journal for immunotherapy of cancer / J Immunother Cancer. 2022 Feb;10(2):e004374. doi: 10.1136/jitc-2021-004374.
2022
AO Ordine Mauriziano
D'Alessio A; Fulgenzi CAM; Besse B; Awad MM; Pinato DJ; Tiseo M; Evans JS; Newsom-Davis T; McKenzie H; Cave J; Caglio A; Di Maio M; Comins C; Artingstall J; Nana FA; Valerie L; Hoton D; Gorría T; Mezquita L; Addeo A; Friedlaender A; Facchinetti F; Andrini E; Lamberti G; Piedra A; Chan S; Majem M; Muthuramalingam S; Banna GL; et alii...
Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysis. in Immunotherapy / Immunotherapy. 2022 Feb;14(2):145-153. doi: 10.2217/imt-2021-0157. Epub 2021 Nov 22.
2022
AO Ordine Mauriziano
Di Maio M; Brunelli M; Mazzaschi G; Cattrini C; Bersanelli M; Buti S;
Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature. in Cancer treatment reviews / Cancer Treat Rev. 2022 Feb;103:102326. doi: 10.1016/j.ctrv.2021.102326. Epub 2021 Dec 23.
2022
AO Ordine Mauriziano
Cremolini C; Di Maio M; Masi G; Tamburini E; Passardi A; Latiano TP; Boccaccino A; Conca V; Zaniboni A; Antoniotti C; Pagani F; Allegrini G; Daniel F; Bergamo F; Pietrantonio F; Santini D; Germani MM; Rossini D; Crespi V; Lombardi P;
Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)". in International journal of cancer / Int J Cancer. 2022 Dec 15;151(12):2291-2292. doi: 10.1002/ijc.34246. Epub 2022 Sep 5.
2022
AO Ordine Mauriziano
Olmos D; Di Maio M; Messina C; Gennari A; Mennitto A; Cattrini C;
Patient-reported outcomes in adoptive cell-therapy trials: mind the gap. in Journal for immunotherapy of cancer / J Immunother Cancer. 2022 Dec;10(12):e006082. doi: 10.1136/jitc-2022-006082.
2022
AO Ordine Mauriziano
Di Maio M; Trueb L; Coukos G; Eicher M; Morotti M; Colomer-Lahiguera S; Ghisoni E;
Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Dec;74(6):703-713. doi: 10.23736/S2724-6051.22.04701-2. Epub 2022 Feb 11.
2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Pisano C; DI Maio M; Tucci M; Scagliotti GV; Samuelly A; DI Stefano RF; Turco F; Bungaro M; Parente A; Buttigliero C; Angusti T;
Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020. in ESMO open / ESMO Open. 2022 Dec;7(6):100593. doi: 10.1016/j.esmoop.2022.100593. Epub 2022 Oct 12.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Di Maio M; Mariniello A; Perrone F; Reale ML; Gargiulo P; Di Liello R; Gamba T; Caglio A; Bungaro M; Audisio M; Paratore C; Zichi C;
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab. in International journal of cancer / Int J Cancer. 2022 Aug 1;151(3):473-480. doi: 10.1002/ijc.34033. Epub 2022 Apr 29.
2022
AO Ordine Mauriziano
Ciardiello F; Martinelli E; Di Maio M; Troiani T; Morgillo F; Tuccillo C; Federico A; Maiello E; Romano M; Loguercio C; Gravina AG; Fasano M; Napolitano S; Corte CMD; Esposito L; Dallio M; Famiglietti V; Ciardiello D; Martini G;
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy. in Cancer communications (London, England) / Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22.
2022
ASL Asti
ASL Cuneo 2
ASL Torino 4
ASL Cuneo 1
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Turco F; Ungaro A; Audisio M; Scagliotti GV; Di Maio M; Delcuratolo MD; Audisio A; Ortega C; Pisano C; Buttigliero C; Di Stefano RF; Tucci M;
Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera statement. in ESMO open / ESMO Open. 2022 Aug;7(4):100538. doi: 10.1016/j.esmoop.2022.100538. Epub 2022 Jun 23.
2022
AO Ordine Mauriziano
Zagonel V; Traclò F; Zocchi MT; Petrini F; Bellani M; Gobber G; Cinieri S; Di Maio M; Perrone F; Corsi DC; Beretta GD; Casolino R;
Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM). in ESMO open / ESMO Open. 2022 Aug;7(4):100548. doi: 10.1016/j.esmoop.2022.100548. Epub 2022 Jul 16.
2022
AO Ordine Mauriziano
Cinieri S; Baldanti F; Di Maio M; Silvestris N; Sapuppo E; Ferrari A; Bergami F; Pedrazzoli P; Lasagna A; Cassaniti I;
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2022 Apr;71(4):865-874. doi: 10.1007/s00262-021-03045-9. Epub 2021 Aug 31
2022
AO Ordine Mauriziano
Brocco D; Porzio G; Piras M; Rijavec E; Simionato F; Natoli C; Santini D; Vincenzi B; Tonini G; Tiseo M; Marconcini R; Audisio M; Intagliata S; Lai E; Aprile G; Buti S; Ghidini M; Inno A; Macrini S; Di Marino P; Nicolardi L; Tuzi A; Occhipinti MA; Pergolesi F; Veltri E; Filetti M; Adamo V; Ficorella C; Citarella F; et alii...
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103639. doi: 10.1016/j.critrevonc.2022.103639. Epub 2022 Feb 19
2022
ASL Asti
AOU Città della Salute di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Novello S; Scagliotti GV; Carnio S; Buffoni L; Passiglia F; Zichi C; Capelletto E; Reale ML; Artusio E; Olmetto E; Bertaglia V; Paratore C; Bungaro M; Curcio H; De Luca E; Tagliamento M; Audisio M; Rapetti SG; Bironzo P; Pignataro D; Di Maio M;
Immunotherapy in advanced anal cancer: Is the beginning of a new era? in Cancer treatment reviews / Cancer Treat Rev. 2022 Apr;105:102373. doi: 10.1016/j.ctrv.2022.102373. Epub 2022 Mar 8.
2022
AO Ordine Mauriziano
Maiello E; Troiani T; Martinelli E; Ciardiello F; Latiano TP; Di Maio M; Parente P; Maiorano BA; Ciardiello D; Guerrera LP;
Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103649. doi: 10.1016/j.critrevonc.2022.103649. Epub 2022 Mar 5.
2022
AO Ordine Mauriziano
Formisano L; Bianco R; Di Maio M; De Placido P; De Placido S; Santaniello A; Napolitano F; Marandino L; Iuliano R; Salomone F; Di Costanzo F; Servetto A;
A multicenter randomized phase 4 trial comparing sodium picosulphate plus magnesium citrate vs. polyethylene glycol plus ascorbic acid for bowel preparation before colonoscopy. The PRECOL trial. in Frontiers in medicine / Front Med (Lausanne). 2022 Dec 8;9:1013804. doi: 10.3389/fmed.2022.1013804. eCollection 2022.
2022
AO Ordine Mauriziano
Perrone F; de Bellis M; Della Valle E; De Filippo FR; Pumpo R; Taranto D; Sessa G; Esposito P; Salerno R; Miranda A; Romano M; Tracey MC; Tempesta AM; Rossi GB; Di Girolamo E; Marone P; Civiletti C; Bucci C; D'Angelo V; Di Maio M; Gallo C; Piccirillo MC;
Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey. in Frontiers in oncology / Front Oncol. 2022 May 27;12:880008. doi: 10.3389/fonc.2022.880008. eCollection 2022.
2022
AO Ordine Mauriziano
Pignata S; Valabrega G; Ronzino G; Pisano C; Di Maio M; Savarese A; Zamagni C; Artioli G; Lorusso D; Cormio G; Salutari V; Mangili G; Mammoliti S; Bartoletti M; Valsecchi AA; Turinetto M; Scotto G; Tuninetti V; Giannone G; Castaldo D;
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial. in Frontiers in oncology / Front Oncol. 2022 Sep 15;12:925366. doi: 10.3389/fonc.2022.925366. eCollection 2022.
2022
AO Ordine Mauriziano
AO Cuneo
ASL Cuneo 1
AOU Alessandria
Mariani G; Di Pede P; Spinelli GP; Santini D; Zustovich F; Bossi P; Di Maio M; Numico G; Gunnellini M; Rossi M; Giordano M; Corsi DC; Fabi A; Berruti A; Coletta D; Sbrana A; Galli L; Miccinesi G; Velutti L; Sammarco E; Roila F; Antonuzzo A; Ripamonti CI;
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2021 Sep;24(3):812-825. doi: 10.1038/s41391-021-00336-1. Epub 2021 Fe
2021
ASL Asti
ASL Vercelli
AO Ordine Mauriziano
Di Maio M; Scagliotti GV; Gallicchio M; Vignani F; Pisano C; Bungaro M; Samuelly A; Turco F; Tucci M; Di Stefano RF; Buttigliero C;
Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system. in BMJ open / BMJ Open. 2021 Oct 20;11(10):e049128. doi: 10.1136/bmjopen-2021-049128.
2021
AO Ordine Mauriziano
Riva S; Arenare L; Di Maio M; Efficace F; Montesarchio V; Frontini L; Giannarelli D; Bryce J; Del Campo L; De Lorenzo F; Iannelli E; Traclò F; Gitto L; Jommi C; Vaccaro CM; Barberio D; Cinieri S; Porta C; Del Mastro L; Zagonel V; Cogoni AA; Bordonaro R; Gimigliano A; Piccirillo MC; Guizzaro L; Gallo C; Perrone F;
Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study. in ESMO open / ESMO Open. 2021 Oct;6(5):100246. doi: 10.1016/j.esmoop.2021.100246. Epub 2021 Aug 17.
2021
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Di Maio M; Pietrantonio F; Di Bartolomeo M; Corallo S; Morano F; Ratti M; Berenato R; Zaniboni A; Clavarezza M; Murialdo R; Ritorto G; Tampellini M; Amatu A; Smiroldo V; Antoniotti C; Lonardi S; Leone AG; Raimondi A; Fucà G;
[Early access programs and managed entry agreements for medicines in Italy: results of a Focus Group (Early Access Programs and Managed Entry Agreement).]. in Recenti progressi in medicina / Recenti Prog Med. 2021 Nov;112(11):749-756. doi: 10.1701/3696.36853.
2021
AO Ordine Mauriziano
Jommi C; Armeni P; Costa F; Alberti C; Bandello F; Bordonaro R; Caprodossi A; Di Maio M; Gaudioso A; Giuliani G; Langella R; Marata AM; Patarnello F; Pinto C; Rasi G; Villa F;
Hurrying up but not rushing, acting and not reacting, good sense and not common sense: Open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Nov;167:103271. doi: 10.1016/j.critrevonc.2021.103271. Epub 2021 Feb 26
2021
AO Ordine Mauriziano
Di Maio M; Loupakis F; Giusti R;
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations. in Cancers / Cancers (Basel). 2021 May 17;13(10):2425. doi: 10.3390/cancers13102425.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Scagliotti GV; Bussolino F; Righi L; Di Maio M; Passiglia F; Caglio A; Listì A; Sperone T; Tabbò F; Reale ML; Bironzo P; Novello S;
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials. in BMC cancer / BMC Cancer. 2021 May 14;21(1):549. doi: 10.1186/s12885-021-08323-4.
2021
AO Ordine Mauriziano
Perrone F; Piccirillo MC; Di Maio M; Gallo C; Schettino C; Gargiulo P; Arenare L; Gravina A; Esposito G; Della Corte CM; Morgillo F; Mancuso G; Di Liello R; Palumbo G; Ciardiello F; Gebbia V; Maione P; Spagnuolo A; Morabito A; Gridelli C;
Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;149:153-164. doi: 10.1016/j.ejca.2021.03.010. Epub 2021 Apr 14.
2021
AO Ordine Mauriziano
Peters S; Coukos G; Zimmermann S; Mederos Alfonso NN; Homicsko K; Obeid M; Aglietta M; Valabrega G; Marandino L; Tavazzi E; Gatta R; Pradervand S; Özdemir BC; Caikovski M; Latifyan S; Gautron Moura B; Gérard CL; Imbimbo M; Delyon J; Bouchaab H; Ghisoni E; Wicky A; Cuendet MA; Di Maio M; Michielin O;
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;149:49-60. doi: 10.1016/j.ejca.2021.03.007. Epub 2021 Apr 3.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Perrone F; Gamba T; Caglio A; Bungaro M; Audisio M; Reale ML; Gargiulo P; Mariniello A; Di Maio M; Zichi C; Paratore C;
Post-progression outcomes of NSCLC patients with PD-L1 expression ? 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12.
2021
AOU San Luigi di Orbassano
AO Ordine Mauriziano
AOU Novara
Russo A; Adamo V; Metro G; De Filippis M; Simona C; Natalizio S; Migliorino MR; Ricciardi S; Landi L; Minuti G; Buti S; Nigro O; Cantini L; Russano M; Citarella F; Bracarda S; Filetti M; Zoratto F; Mansueto G; De Tursi M; Gori S; Rocco D; Chiari R; Rastelli F; Gelibter A; Targato G; Signorelli D; De Toma A; Mazzoni F; et alii...
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2). in Journal for immunotherapy of cancer / J Immunother Cancer. 2021 May;9(5):e002619. doi: 10.1136/jitc-2021-002619.
2021
AO Ordine Mauriziano
ASL Torino 4
AOU Alessandria
Buti S; Filetti M; Migliorino MR; Russo A; Negrini G; Pinto C; Di Costanzo F; Tognetto M; Tiseo M; Leonardi F; Guadalupi V; Zucali PA; Sorarù M; Laera L; Camerini A; Cinieri S; Baldessari C; Zustovich F; Mencoboni M; Accettura C; Fratino L; Guaitoli G; Rizzo M; Verderame F; Montesarchio V; Casadei C; Ficorella C; Grossi F; Rossi E; et alii...
Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH survey. in Clinics and research in hepatology and gastroenterology / Clin Res Hepatol Gastroenterol. 2021 May;45(3):101681. doi: 10.1016/j.clinre.2021.101681. Epub 2021
2021
AO Ordine Mauriziano
Basile D; Gallois C; Puglisi F; Cohen R; Goere D; Aprile G; Lepage C; Laurent-Puig P; Di Maio M; Lecomte T; Pernot S; Zaanan A; Taieb J;
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab. in Journal of clinical medicine / J Clin Med. 2021 Mar 2;10(5):1005. doi: 10.3390/jcm10051005.
2021
AO Ordine Mauriziano
Di Maio M; Chiari R; Ficorella C; Cortellini A; Aerts S; Caglio A; Nicolardi L; Rinaldi S; Paoloni F; Ranallo N; Lupi A; Mentrasti G; Agostinelli V; Cognigni V; Pecci F; Cantini L; Lenci E; Dingemans AC; Aerts JGJV; Berardi R;
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study. in Cancers / Cancers (Basel). 2021 Mar 16;13(6):1324. doi: 10.3390/cancers13061324.
2021
AO Ordine Mauriziano
Raimondi A; Olgiati A; Montagna B; Manzoni M; La Verde N; Lasagna A; Grossi F; Giordano M; D'Antonio F; Bernocchi O; Catania G; Balletti E; Zucali PA; Poggi G; Pietrantonio F; Nolè F; Palmeri L; Luciani A; Farina G; Luchena G; Borgonovo K; Bernardo A; Agustoni F; Giudici F; Tagliaferri B; Generali D; Di Cosimo S; Rampinelli I; Verri E; et alii...
Synaptophysin expression in (V600EBRAF-)mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Mar;146:145-154. doi: 10.1016/j.ejca.2021.01.016. Epub 2021 Feb 16.
2021
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Dei Tos AP; Lonardi S; Zagonel V; Borga C; Biason P; Centonze G; Santini D; Salmaso R; Aprile G; Salvatore L; Calvetti L; Smiroldo V; Rimassa L; De Maglio G; Cortiula F; Morano F; Volante M; Boccaccino A; Bergamo F; Zichi C; Sperti E; Dell'Aquila E; Pella N; Pietrantonio F; Schirripa M; Cremolini C; Maddalena G; Milione M; Fassan M; et alii...
TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study. in Cancers / Cancers (Basel). 2021 Jun 7;13(11):2839. doi: 10.3390/cancers13112839.
2021
AO Ordine Mauriziano
AO Cuneo
Zaniboni A; Tamburini E; Tamberi S; Strippoli A; Spallanzani A; Smiroldo V; Silvestris N; Ratti M; Pucci F; Ongaro E; Murialdo R; Lonardi S; Iachetta F; Granetto C; Fornaro L; Frassineti GL; Di Maio M; De Vita F; De Manzoni G; Cardellino GG; Berardi R; Aprile G; Antonuzzo L; Aglietta M; Prisciandaro M; Di Bartolomeo M; Palermo F; Raimondi A; Cremolini C; et alii...
Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC. in Endocrine-related cancer / Endocr Relat Cancer. 2021 Jun 2;28(7):R207-R216. doi: 10.1530/ERC-20-0457.
2021
ASL Asti
ASL Vercelli
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Buttigliero C; Di Maio M; Scagliotti GV; Pisano C; Audisio M; Samuelly A; Bungaro M; Tucci M; Di Stefano RF; Turco F;
A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2021 Jun;29(6):3219-3233. doi: 10.1007/s00520-020-05840-z. Epub 2020 Oct 22.
2021
AO Ordine Mauriziano
Piccirillo MC; Sparavigna L; Savio A; Romano F; Gimigliano A; Canzanella G; Arenare L; Vaccaro CM; Traclò F; Montesarchio V; Jommi C; Iannelli E; Gitto L; Giannarelli D; Frontini L; De Lorenzo F; Bryce J; Del Campo L; Di Maio M; Riva S; Efficace F; Guizzaro L; Gallo C; Perrone F;
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:224-231. doi: 10.1016/j.ejca.2021.03.041. Epub 2021 May 3.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara
Cannita K; Porzio G; Friedlaender A; Addeo A; Banna GL; Spinelli GP; Russo A; Adamo V; Metro G; Olmetto E; Tabbò F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Tuzi A; Bisonni R; Follador A; Siringo M; Gelibter A; Signorelli D; De Toma A; Garassino MC; Mazzoni F; Russano M; Citarella F; Filetti M; Zoratto F; Mansueto G; et alii...
First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jun;10(6):2917-2936. doi: 10.21037/tlcr-21-15.
2021
AO Ordine Mauriziano
Facchinetti F; Di Maio M; Perrone F; Tiseo M;
Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jun;10(6):2890-2916. doi: 10.21037/tlcr-20-941.
2021
AO Ordine Mauriziano
Guaitoli G; Tiseo M; Di Maio M; Friboulet L; Facchinetti F;
Heterogeneity of treatment effects in malignant pleural mesothelioma. in Lancet (London, England) / Lancet. 2021 Jul 24;398(10297):301-302. doi: 10.1016/S0140-6736(21)00882-5.
2021
AO Ordine Mauriziano
Di Maio M; Tagliamento M;
Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study. in Journal of cardiovascular pharmacology / J Cardiovasc Pharmacol. 2021 Jul 1;78(1):e94-e100. doi: 10.1097/FJC.0000000000001041.
2021
ASL Torino 3
AO Ordine Mauriziano
Di Maio M; Di Micco P; Varbella F; Albani S; Musumeci G; Celentani D; Parodi G; Nunziata L; Attena E; D'Andrea A; Scudiero F; Silverio A; Russo V;
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature. in Gynecologic oncology / Gynecol Oncol. 2021 Jul;162(1):80-87. doi: 10.1016/j.ygyno.2021.04.018. Epub 2021 Apr 22.
2021
AO Ordine Mauriziano
ASL VCO
ASL Biella
AOU Città della Salute di Torino
Di Maio M; Pasini B; Valabrega G; Aglietta M; Gemmiti S; Turinetto M; Zavallone L; Mittica G; Mangiacotti S; Villa M; Tuninetti V; Ferrero A; Ghisoni E; Farolfi A; Borella F; Cosma S; Giannone G; Scotto G; De Giorgi U; Katsaros D;
A narrative review of primary research endpoints of neoadjuvant therapy for lung cancer: past, present and future. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jul;10(7):3264-3275. doi: 10.21037/tlcr-21-259.
2021
AO Ordine Mauriziano
Ren S; Xu A; Lin Y; Camidge DR; Di Maio M; Califano R; Hida T; Rossi A; Guibert N; Zhu C; Shen J;
Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103185. doi: 10.1016/j.critrevonc.2020.103185. Epub 2020 Nov 27
2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano
Buttigliero C; Di Maio M; Scagliotti GV; Di Stefano RF; Turco F; Tucci M; Pisano C;
Luteinized thecoma (thecomatosis) with sclerosing peritonitis: a systematic review of the literature of the last 25 years. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2021 Jan;21(1):23-32. doi: 10.1080/14737140.2021.1837629. Epub 2020 Oct
2021
AO Ordine Mauriziano
Delcuratolo MD; Sperone P; Di Maio M; Trevisi E; Muratori L;
Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study. in Cancers / Cancers (Basel). 2021 Dec 23;14(1):69. doi: 10.3390/cancers14010069.
2021
AO Ordine Mauriziano
Pusceddu S; Vernieri C; Di Maio M; Prinzi N; Torchio M; Corti F; Coppa J; Buzzoni R; Di Bartolomeo M; Milione M; Regnault B; Truong Thanh XM; Mazzaferro V; de Braud F;
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):803-814. doi: 10.23736/S2724-6051.21.04186-2. Epub 2021 Mar 29.
2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
ASL Torino 4
AO Ordine Mauriziano
Buttigliero C; DI Maio M; Scagliotti GV; Tarenghi F; Vignani F; Bungaro M; Samuelly A; Turco F; DI Stefano RF; Tucci M; Pisano C;
Equity in Drug Accessibility: The Surprising Case of Treatments for Metastatic Castration-sensitive Prostate Cancer in European Countries. in European urology oncology / Eur Urol Oncol. 2021 Dec;4(6):1011-1012. doi: 10.1016/j.euo.2021.08.002. Epub 2021 Sep 15.
2021
AO Ordine Mauriziano
Caffo O; Di Maio M;
Descriptive Comparative Analysis of Patients With Cancer Referring to the Emergency Department of an Italian University Hospital Across the Severe Acute Respiratory Syndrome Coronavirus 2 Waves. in JCO oncology practice / JCO Oncol Pract. 2021 Dec;17(12):e1887-e1894. doi: 10.1200/OP.21.00098. Epub 2021 Jul 6.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Passiglia F; Capelletto E; Boccuzzi A; Caramello V; Olmetto E; Persano I; De Filippis M; Pisano C; Bironzo P; Mariniello A; Di Maio M; Novello S;
COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave? in ESMO open / ESMO Open. 2021 Apr;6(2):100100. doi: 10.1016/j.esmoop.2021.100100. Epub 2021 Mar 19.
2021
ASL Asti
ASL Vercelli
AO Ordine Mauriziano
Cinieri S; Tucci M; Beretta GD; La Verde N; Giuffrida D; Del Mastro L; De Giorgi U; Chiari R; Russo A; Di Maio M; Silvestris N; Perrone F;
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. in Journal for immunotherapy of cancer / J Immunother Cancer. 2021 Apr;9(4):e002421. doi: 10.1136/jitc-2021-002421.
2021
AOU San Luigi di Orbassano
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara
Russo A; Adamo V; Metro G; Bironzo P; Passiglia F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Bordi P; Tuzi A; Cantini L; Russano M; Citarella F; Santini D; Filetti M; Zoratto F; Mansueto G; Di Marino P; Grassadonia A; Michele T; Inno A; Della Gravara L; Rocco D; Chiari R; Rastelli F; Macerelli M; Marchetti P; Siringo M; et alii...
Second medical opinion in oncological setting. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Apr;160:103282. doi: 10.1016/j.critrevonc.2021.103282. Epub 2021 Mar 3.
2021
AO Ordine Mauriziano
Gori S; Marchetti P; Scagnoli S; Maruzzo M; La Verde N; Russo A; Nicolis F; Cinieri S; Comandone A; Bordonaro R; Beretta G; Lanzetta G; Perrone F; Galvano A; Zagonel V; Di Maio M; Gonzato O;
Multidisciplinary oral therapy outpatient clinic: An italian single centre experience in European Journal of Hospital Pharmacy
2021
AO Ordine Mauriziano
Di Maio M; Gasco A; Ciriolo G; Paratore C; Codegone F; Zichi C; Sperti E; Terzolo S; Marino D; Bellero M; Fazzina G;
A multicenter, retrospective study on impact of immunotherapy in urothelial carcinoma with bone metastases (Meet-Uro01 Study) in Journal of Clinical Oncology
2021
AO Ordine Mauriziano
Giannatempo P; Marandino L; Raggi D; Pierantoni F; Maruzzo M; Lipari H; Banna GL; De Giorgi U; Naglieri E; Buti S; Stellato M; Vignani F; Roviello G; Veccia A; Losanno T; Mucciarini C; Pignata S; Necchi A; Di Maio M;
FP12.06 GRIm-Score Variations Predict Outcome in Metastatic NSCLC Patients Treated with First-Line Pembrolizumab in Journal of Thoracic Oncology
2021
AO Ordine Mauriziano
Caglio A; Aerts S; Berardi R; Dingemans A; Nicolardi L; Lupi A; Paoloni F; Cortellini A; Ficorella C; Chiari R; Di Maio M; Aerts J; Agostinelli V; Mentrasti G; Ranallo N; Lenci E; Cantini L; Rinaldi S; Pecci F; Cognigni V;
Evaluation of Cognitive Function in Trials Testing New-Generation Hormonal Therapy in Patients with Prostate Cancer: A Systematic Review. in Cancers / Cancers (Basel). 2020 Sep 9;12(9):2568. doi: 10.3390/cancers12092568.
2020
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano
ASL Vercelli
Tucci M; Di Maio M; Necchi A; Gamba T; Buttigliero C; Vignani F; Marandino L;
Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials. in Cancers / Cancers (Basel). 2020 Sep 16;12(9):2645. doi: 10.3390/cancers12092645.
2020
AO Ordine Mauriziano
Di Maio M; Tiseo M; Facchinetti F;
DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non-Small-Cell Lung Cancer: An External Validation. in Clinical lung cancer / Clin Lung Cancer. 2020 Sep;21(5):e337-e348. doi: 10.1016/j.cllc.2020.01.005. Epub 2020 Mar 7.
2020
AO Ordine Mauriziano
Prelaj A; Lo Russo G; Proto C; Signorelli D; Ferrara R; Galli G; De Toma A; Randon G; Pagani F; Trevisan B; Ganzinelli M; Zilembo N; Montrone M; Longo V; Pesola F; Pizzutilo P; Del Bene G; Varesano N; Galetta D; Torri V; Garassino MC; Di Maio M; Catino A;
Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study). in American journal of clinical oncology / Am J Clin Oncol. 2020 Sep;43(9):621-627. doi: 10.1097/COC.0000000000000719.
2020
AO Ordine Mauriziano
Sepe P; Martinetti A; Mennitto A; Verzoni E; Claps M; Raimondi A; Sottotetti E; Grassi P; Guadalupi V; Stellato M; Zattarin E; Di Maio M; Procopio G;
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak. in European journal of clinical investigation / Eur J Clin Invest. 2020 Sep;50(9):e13315. doi: 10.1111/eci.13315. Epub 2020 Jul 5.
2020
AO Ordine Mauriziano
Tagliamento M; Spagnolo F; Poggio F; Soldato D; Conte B; Ruelle T; Barisione E; De Maria A; Del Mastro L; Di Maio M; Lambertini M;
Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM). in Breast (Edinburgh, Scotland) / Breast. 2020 Oct;53:18-22. doi: 10.1016/j.breast.2020.06.002. Epub 2020 Jun 5.
2020
AO Ordine Mauriziano
Aieta M; Prete SD; Pisconti S; Romito S; Cinefra M; Ciccarese M; Caliolo C; Quaranta A; Fedele P; Schiavone P; Di Maio M; Giotta F; Lorusso V; Orlando L; Rizzi D; Maiello E; Colucci G; Cinieri S;
[Outcomes reported by the patient: a tool for respecting the patient's rights and for involvement in research.]. in Recenti progressi in medicina / Recenti Prog Med. 2020 Nov;111(11):685-689. doi: 10.1701/3474.34575.
2020
AO Ordine Mauriziano
Di Maio M;
Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research Activities. in JCO oncology practice / JCO Oncol Pract. 2020 Nov;16(11):e1304-e1314. doi: 10.1200/OP.20.00297. Epub 2020 Jun 23.
2020
AO Ordine Mauriziano
Poggio F; Tagliamento M; Di Maio M; Martelli V; De Maria A; Barisione E; Grosso M; Boccardo F; Pronzato P; Del Mastro L; Lambertini M;
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
ASL Città di Torino
Banna GL; Camisa R; Di Maio M; Rossi G; Rossi A; Cortinovis DL; Bria E; Novello S; Baldessari C; Bartoli G; Pizzutilo EG; Landi L; Toschi L; Dall'Olio FG; Sartori G; Ciccone LP; Garassino MC; Guaitoli G; Zanelli F; De Carlo E; Camerini A; Bearz A; Sala E; Cerea G; Migliorino MR; Bennati C; Ardizzoni A; Vita E; Rossi S; et alii...
Real-World Evidence in Oncology: Opportunities and Limitations. in The oncologist / Oncologist. 2020 May;25(5):e746-e752. doi: 10.1634/theoncologist.2019-0647. Epub 2019 Dec 24.
2020
AO Ordine Mauriziano
Conte P; Di Maio M; Perrone F;
Quality of life in patients with lung cancer: the way forward. in The Lancet. Oncology / Lancet Oncol. 2020 May;21(5):617-619. doi: 10.1016/S1470-2045(20)30151-0. Epub 2020 Mar 23.
2020
AO Ordine Mauriziano
Reale ML; Di Maio M;
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2020 Mar 1;26(5):1017-1024. doi: 10.1158/1078-0432.CCR-19-3024. Epub 2019 Nov 18.
2020
AO Ordine Mauriziano
Milione M; Di Nicolantonio F; Tamborini E; Perrone F; Barault L; Macagno M; Martinetti A; Palermo F; Guarini V; Pagani F; Corallo S; Randon G; Gori S; Petrelli F; Farina G; Longarini R; Tomasello G; Sartore-Bianchi A; Murgioni S; Rimassa L; Mosconi S; Morano F; Raimondi A; Lonardi S; Antista M; Lobefaro R; Pietrantonio F; Di Maio M; Fucà G; et alii...
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer. in Liver international : official journal of the International Association for the Study of the Liver / Liver Int. 2020 Mar;40(3):704-711. doi: 10.1111/liv.14314. Epub 2019 Dec 11.
2020
ASL Cuneo 2
ASL Biella
AOU Città della Salute di Torino
AO Ordine Mauriziano
Casadei-Gardini A; Aprile G; Roviello G; Scartozzi M; Cascinu S; Silvestris N; Spallanzani A; Santini D; Gelsomino F; Depetris I; Cagnazzo C; Lombardi P; Fenocchio E; Sperti E; Di Maio M; Ortega C; Fornaro L; Aglietta M; Leone F; Cerma K; Salani F; Caputo F; Vivaldi C; Filippi R; Salati M;
Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinion. in ESMO open / ESMO Open. 2020 Mar;5(2):e000652. doi: 10.1136/esmoopen-2019-000652.
2020
AO Ordine Mauriziano
Ibrahim T; Bracarda S; Procopio G; Di Maio M; Berruti A; Santini D; Bertoldo F;
[Could a medication management app help people to optimize their oral cancer drugs intake?]. in Recenti progressi in medicina / Recenti Prog Med. 2020 Mar;111(3):125-126. doi: 10.1701/3315.32851.
2020
AO Ordine Mauriziano
Di Maio M;
Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico / Clin Transl Oncol. 2020 Mar;22(3):294-301. doi: 10.1007/s12094-019-02222-8. Epub 2019 Oct 19.
2020
AOU San Luigi di Orbassano
ASL Città di Torino
AO Ordine Mauriziano
Novello S; Tiseo M; Di Maio M; Galetta D; Bria E; Rossi G; Cortinovis D; Rizzo P; Tabbò F; Delmonte A; Bareggi C; Sergi C; Del Conte A; Graziano P; Gregorc V; Casartelli C; Rossi A; Borra G; Maiello E; Martelli O; Scotti V; Riccardi F; Cecere F; Cappuzzo F; Pilotto S; Osman G; Ghilardi L; Pizzutillo P; Bordi P; et alii...
Carcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature. in Acta oncologica (Stockholm, Sweden) / Acta Oncol. 2020 Mar;59(3):315-319. doi: 10.1080/0284186X.2019.1672891. Epub 2019 Oct 4.
2020
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Atzeni F; Di Maio M; Scagliotti GV; Muratori L; Parisi F; Brizzi MP; Trevisi E; La Salvia A;
The Use of Not-Negative Conclusions to Describe Results of Formally Negative Trials Presented at Oncology Meetings. in JAMA oncology / JAMA Oncol. 2020 Jun 1;6(6):926-927. doi: 10.1001/jamaoncol.2020.0475.
2020
AO Ordine Mauriziano
Zichi C; Gargiulo P; Cardone C; De Luca E; Audisio M; Di Maio M; Perrone F;
COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical Practice. in JCO oncology practice / JCO Oncol Pract. 2020 Jun;16(6):295-298. doi: 10.1200/OP.20.00237. Epub 2020 May 1.
2020
AO Ordine Mauriziano
Marandino L; Necchi A; Aglietta M; Di Maio M;
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders. in The oncologist / Oncologist. 2020 Jun;25(6):e946-e954. doi: 10.1634/theoncologist.2020-0035. Epub 2020 Mar 17.
2020
ASL Città di Torino
AO Ordine Mauriziano
Danova M; De Luca E; Di Maio M; Farroni F; Egidi MF; Giacomelli L; Presotto EM; Peri A; Cortinovis D; Tagliaferri E; Pasqualetti G; Spina F; Sebastiani GD; Roila F; Quaglino P; Antonuzzo A; Calabrò F; Scottè F; Jordan K; Bossi P;
Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell'Italia Meridionale (GOIM 2802). in Clinical colorectal cancer / Clin Colorectal Cancer. 2020 Jun;19(2):109-115. doi: 10.1016/j.clcc.2020.01.003. Epub 2020 Jan 30.
2020
AO Ordine Mauriziano
Maiello E; Di Maggio G; Cordio S; Cinieri S; Giuliani F; Pisconti S; Rinaldi A; Febbraro A; Latiano TP; Aieta M; Rossi A; Rizzi D; Di Maio M; Colucci G; Bordonaro R;
Neuroendocrine breast carcinoma: a rare but challenging entity. in Medical oncology (Northwood, London, England) / Med Oncol. 2020 Jul 25;37(8):70. doi: 10.1007/s12032-020-01396-4.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Di Maio M; De Rosa G; Scagliotti GV; Brizzi MP; La Salvia A; Daniele L; Trevisi E;
The Shifting Landscape of Genitourinary Oncology During the COVID-19 Pandemic and how Italian Oncologists Reacted: Results from a National Survey. in European urology / Eur Urol. 2020 Jul;78(1):e27-e35. doi: 10.1016/j.eururo.2020.04.004. Epub 2020 Apr 20.
2020
AO Ordine Mauriziano
Marandino L; Di Maio M; Procopio G; Cinieri S; Beretta GD; Necchi A;
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jan;139:47-54. doi: 10.1016/j.lungcan.2019.10.022. Epub 2019 Oct 31.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Di Maio M; Perrone F; Novello S; Scagliotti GV; Aglietta M; Bironzo P; Sonetto C; La Salvia A; Muratori L; Trevisi E; Leone G; Mariniello A; Di Stefano RF; Pignataro D; Ghisoni E; Zichi C; Marandino L; Lombardi P; De Luca E; Reale ML;
Impact of primary tumor location on patterns of recurrence and survival of patients undergoing resection of liver metastases from colon cancer. in HPB : the official journal of the International Hepato Pancreato Biliary Association / HPB (Oxford). 2020 Jan;22(1):116-123. doi: 10.1016/j.hpb.2019.05.014. Epub 2019 Jun 22.
2020
AO Ordine Mauriziano
Sperti E; Russolillo N; Langella S; Menonna F; Allieta A; Di Maio M; Ferrero A;
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102877. doi: 10.1016/j.critrevonc.2020.102877. Epub 2020 Jan 18
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Perrone F; Scagliotti GV; Aglietta M; Novello S; Leone F; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Ghisoni E; Di Stefano RF; Pignataro D; Reale ML; De Luca E; Zichi C; Marandino L; Lombardi P; Di Maio M;
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Dec;150:123-131. doi: 10.1016/j.lungcan.2020.10.008. Epub 2020 Oct 22.
2020
AO Ordine Mauriziano
Bearz A; Pizzutilo EG; Cerea G; Fiordoliva I; Berardi R; Giusti R; Filetti M; Audisio M; Bordi P; Di Maio M; Russano M; Santini D; Di Marino P; De Tursi M; Ciccone LP; Scotti V; Mazzoni F; Lavacchi D; Rapacchi E; Ghilardi L; Bettini AC; Giaiacopi E; Qako E; D'Argento E; Sartori G; Vita E; Rossi S; Randon G; Marinello A; et alii...
Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients. in Recenti progressi in medicina / Recenti Prog Med. 2020 Dec;111(12):740-748. doi: 10.1701/3509.34965.
2020
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Zilio E; Pozzi D; Polimeno L; Ciriolo G; Comite R; Codegone F; Florio S; Fusco L; Audisio M; Ballaminut D; Bellezza A; Chiotto P; Zichi C; De Luca E; Vignani F; Sperti E; Guida G; Turco CGC; Lacidogna G; Baratelli C; Marino D; Terzolo S; Di Maio M;
Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2020 Dec;72(6):737-745. doi: 10.23736/S0393-2249.20.03708-X. Epub 2020 Apr 10.
2020
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Di Maio M; Numico G; Scagliotti GV; Guglielmini P; Lacidogna G; Turco F; Di Stefano RF; Pisano C; Buttigliero C; Tucci M; Sonetto C; Vignani F;
Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2696-2715. doi: 10.21037/tlcr-2020-63.
2020
AO Ordine Mauriziano
Liang W; Cai K; Chen C; Chen H; Chen Q; Fu J; Hu J; Jiang T; Jiao W; Li S; Liu C; Liu D; Liu W; Liu Y; Ma H; Pan X; Qiao G; Tian H; Wei L; Zhang Y; Zhao S; Zhao X; Zhou C; Zhu Y; Zhong R; Li F; Rosell R; Provencio M; Massarelli E; et alii...
Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 Aug 20:JCO2001225. doi: 10.1200/JCO.20.01225.
2020
AO Ordine Mauriziano
Cremolini C; Antoniotti C; Stein A; Bendell J; Gruenberger T; Rossini D; Masi G; Ongaro E; Hurwitz H; Falcone A; Schmoll HJ; Di Maio M;
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience. in Cancers / Cancers (Basel). 2020 Aug 10;12(8):2239. doi: 10.3390/cancers12082239.
2020
AO Ordine Mauriziano
Pignata S; Scaffa C; De Simone M; Vaira M; Ponzone R; Siatis D; Turinetto M; Giannone G; Scotto G; Robella M; Maggiorotto F; Ghisoni E; Di Napoli M; Tuninetti V; Greggi S; Di Maio M; Valabrega G;
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24
2020
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano
Di Maio M; Tucci M; Scagliotti GV; Vignani F; Turco F; Tabbò F; Pisano C; Di Stefano RF; Buttigliero C; Leone G;
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Aug;135:230-239. doi: 10.1016/j.ejca.2020.04.048. Epub 2020 Jul 2.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Pietrantonio F; Di Bartolomeo M; Peverelli G; de Braud F; Antista M; Niger M; Bergamo F; Cinieri S; Longarini R; Giordano M; Antonuzzo L; Petrelli F; Adamo V; Tomasello G; Zaniboni A; Clavarezza M; Murialdo R; Tampellini M; Ritorto G; Sartore-Bianchi A; Rimassa L; Antoniotti C; Corallo S; Lonardi S; Morano F; Raimondi A; Di Maio M;
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer. in The oncologist / Oncologist. 2020 Aug;25(8):661-668. doi: 10.1634/theoncologist.2019-0780. Epub 2020 Mar 23.
2020
AO Ordine Mauriziano
Pelizzari G; Cortiula F; Montico M; Corvaja C; Garattini SK; Basile D; Gerratana L; Audisio M; Lisanti C; Fanotto V; Ongaro E; Iacono D; Cardellino GG; Foltran L; Pella N; Buonadonna A; Aprile G; Di Maio M; Fasola G; Puglisi F;
The KEY for chemo-immunotherapy combination: taking NOTEs from squamous cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2020 Apr;9(2):410-413. doi: 10.21037/tlcr.2020.02.02.
2020
AO Ordine Mauriziano
Di Maio M; De Luca E; Reale ML;
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Nov 2;12:1758835920968463. doi: 10.1177/1758835920968463. eCollection 2020.
2020
ASL Cuneo 2
AOU San Luigi di Orbassano
ASL Città di Torino
ASL VCO
AO Ordine Mauriziano
AOU Alessandria
Buti S; Tognetto M; Vaccaro V; Di Costanzo F; Maiello E; Labianca R; Pinto C; Garzoli E; Pilotto S; Castro A; Carrozza F; Gori S; Verusio C; Atzori F; Dicorato AM; Giordano P; Corbo C; Gernone A; Prati V; Carnio S; Tassinari D; Cavanna L; Meriggi F; Longo L; Sartori D; Iannopollo M; Pezzuolo D; Bracarda S; Bonetti A; et alii...
Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The Evidence. in Cancer management and research / Cancer Manag Res. 2020 May 20;12:3721-3729. doi: 10.2147/CMAR.S216220. eCollection 2020.
2020
AO Ordine Mauriziano
Di Maio M; Marino D; De Luca E;
The beginning of the COVID-19 era: The perception of oncological patients (pts) in active treatment at the Brindisi and Mauriziano Hospital Oncology Departments in Annals of Oncology
2020
AO Ordine Mauriziano
Loparco D; Di Maio M; Orlando L; Dascanio F; Caliolo C; Ignazzi G; Schiavone P; Lacidogna G; Quaranta A; Marino D; Del Bene G; Vignani F; Fedele P; Sperti E; Caloro M; Terzolo S; D'Amico M; Bellezza A; Comite R; Cinieri S;
Long-lasting, irreversible and lateonset immune-related adverse events (irAEs) from immune checkpoint inhibitors (ICIs): A real-world data analysis in Journal of Clinical Oncology
2020
AO Ordine Mauriziano
Ghisoni E; Wicky AM; Latifyan S; Alfonso NNM; Özdemir BC; Cuendet MA; Imbimbo M; Marandino L; Delyon J; Gerard CL; Tavazzi E; Gatta R; Valabrega G; Aglietta M; Obeid M; Coukos G; Peters S; Di Maio M; Bouchaab H; Michielin O;
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: Retrospective analysis of clinical outcomes in Journal of Clinical Oncology
2020
AO Ordine Mauriziano
ASL Biella
Giannone G; Scotto G; De Giorgi U; Farolfi A; Katsaros D; Borella F; Ferrero A; Villa M; Tuninetti V; Ghisoni E; Turinetto M; Zavallone L; Aglietta M; Pasini B; Di Maio M; Valabrega G;
FOLFOXIRI/bevacizumab (bev) versus doublets/bev as initial therapy of unresectable metastatic colorectal cancer (mCRC): A meta-analysis of individual patient data (IPD) from five randomized trials in Journal of Clinical Oncology
2020
AO Ordine Mauriziano
Cremolini C; Antoniotti C; Stein A; Bendell JC; Gruenberger T; Masi G; Ongaro E; Hurwitz H; Falcone A; Schmoll H-J; Di Maio M;
Neoadjuvant chemoradiation (CRT) for locally advanced rectal cancer (LARC) with or without oxaliplatin (OX): Individual patient data (IPD) meta-analysis of three randomized controlled trials (RCTs) with subgroup analyses of age cohorts in Journal of Clinical Oncology
2020
AO Ordine Mauriziano
Fontana E; Zichi C; Smyth EC; Mauer ME; Roedel C; Fokas E; Hofheinz RD; Arnold D; Schmoll H-J; Van Cutsem E; Haustermans K; Stein A; Gerard J-P; Conroy T; Jouffroy-Zeller C; Moehler MH; Lordick F; Ben-Aharon I; Di Maio M;
Coronavirus: Older Persons With Cancer in Italy in the COVID-19 Pandemic. in Frontiers in oncology / Front Oncol. 2020 Apr 30;10:648. doi: 10.3389/fonc.2020.00648. eCollection 2020.
2020
AO Ordine Mauriziano
Fratino L; Procopio G; Di Maio M; Cinieri S; Leo S; Beretta G;
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol. in BMJ open / BMJ Open. 2019 Sep 9;9(9):e031485. doi: 10.1136/bmjopen-2019-031485.
2019
AO Ordine Mauriziano
Riva S; Bryce J; De Lorenzo F; Del Campo L; Di Maio M; Efficace F; Frontini L; Giannarelli D; Gitto L; Iannelli E; Jommi C; Montesarchio V; Traclò F; Vaccaro CM; Gallo C; Perrone F;
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2019 Oct;17(5):332-347.e2. doi: 10.1016/j.clgc.2019.07.007. Epub 2019 Jul 20
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Novello S; Aglietta M; Tucci M; Buttigliero C; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Ghisoni E; Di Stefano RF; Pignataro D; Reale ML; Lombardi P; Zichi C; De Luca E; Marandino L; Scagliotti GV; Perrone F; Di Maio M;
Women With Synchronous or Metachronous Lung and Ovarian Cancer: A Multi-Institutional Report. in In vivo (Athens, Greece) / In Vivo. 2019 Nov-Dec;33(6):2021-2026. doi: 10.21873/invivo.11699.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Valabrega G; DI Maio M; Zichi C; Giajlevra M; Parra HS; Gelibter A; Cecere F; Barbieri F; Del Conte A; Chiari R; Righi L; Catino A; Novello S; Ghisoni E; Mariniello A;
Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment. in Gynecologic oncology reports / Gynecol Oncol Rep. 2019 Feb 16;28:44-46. doi: 10.1016/j.gore.2019.02.004. eCollection 2019 May.
2019
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Scagliotti GV; Di Maio M; Andreozzi A; Sperone P; Gorzegno G; Muratori L;
Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jul;139:41-52. doi: 10.1016/j.critrevonc.2019.05.002. Epub 2019 May 3.
2019
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Di Maio M; Sperone P; La Salvia A; Muratori L;
The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2019 Dec;27(12):4697-4704. doi: 10.1007/s00520-019-04777-2. Epub 2019 Apr 4.
2019
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Di Maio M; Terzolo S; Zilio E; Pozzi D; Polimeno L; Fusco L; Florio S; Comite R; Codegone F; Ciriolo G; Chiotto P; Bellezza A; Audisio M; Ballaminut D; De Luca E; Marino D; Zichi C; Vignani F; Sperti E; Lacidogna G; Turco CGC; Baratelli C;
Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Aug;14(8):1458-1471. doi: 10.1016/j.jtho.2019.03.029. Epub 2019 May 9.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Papotti M; Di Maio M; Novello S; Righi L; Bussolino F; Ruffini E; Ardissone F; Comunanza V; Passone E; Cartia CF; Tabbò F; Bironzo P; Milosevic V; Ananthanarayanan P; Gagliasso M; Costardi L; Maletta F; Pradotto M; Salaroglio IC; Kopecka J; Napoli F; Scagliotti GV; Riganti C;
Assessing Financial Toxicity in Patients With Cancer: Moving Away From a One-Size-Fits-All Approach. in Journal of oncology practice / J Oncol Pract. 2019 Aug;15(8):460-461. doi: 10.1200/JOP.19.00200. Epub 2019 May 24.
2019
AO Ordine Mauriziano
Perrone F; Di Maio M; Efficace F; Gallo C; Giannarelli D; Montesarchio V; Riva S;
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study in European Journal of Cancer
2019
AO Ordine Mauriziano
Biason P; Lonardi S; Zagonel V; Fassan M; Di Maio M; Buggin F; Prete AA; Depetris I; Morano F; Ongaro E; Cascinu S; Santini D; Ziranu P; Schirripa M; Salvatore L; Calegari MA; Siena S; Prenen H; Negri F; Di Donato S; Buonandi P; Tomasello G; Avallone A; Zustovich F; Moretto R; Antoniotti C; Aprile G; Antonuzzo L; Urbano F; et alii...
Second-line treatment options in hepatocellular carcinoma. in Drugs in context / Drugs Context. 2019 Apr 10;8:212577. doi: 10.7573/dic.212577. eCollection 2019.
2019
AO Ordine Mauriziano
Marino D; Zichi C; Audisio M; Sperti E; Di Maio M;
Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients in Reproductive BioMedicine Online
2019
AO Ordine Mauriziano
Lambertini M; Di Maio M; Poggio F; Pagani O; Curigliano G; Mastro LD; Paluch-Shimon S; Loibl S; Partridge AH; Azim HA; Peccatori FA; Demeestere I;
2019
AO Ordine Mauriziano
AOU Città della Salute di Torino
Pusceddu S; Prinzi N; Torchio M; Vernieri C; Di Maio M; Buzzoni R; Mazzaferro V; Truong Thanh XM; De Braud F; Liberini V; De Santi B; Gallio E; Pilati E; Finessi M; Bellò M; Papotti M; Maletta F; Volante M; Bisi G; Molinari F; Deandreis D;
P2.14-14 Comparison of Molecular Testing Modalities for Detection of NRG1 Rearrangements in Invasive Mucinous Adenocarcinoma in Journal of Thoracic Oncology
2019
AO Ordine Mauriziano
Trombetta D; Fabrizio F; Graziano P; Rossi G; Manzorra M; Sparaneo A; Cento F; Rossi A; Tiseo M; Gnetti L; Di Maio M; Maiello E; Fazio V; Muscarella L;
Measuring financial toxicity of cancer in the Italian health care system: Initial results of the patient reported outcome for fighting financial toxicity of cancer project (proFFiT) in Journal of Clinical Oncology
2019
AO Ordine Mauriziano
Bryce J; Riva S; Di Maio M; Efficace F; Frontini L; Gallo C; Giannarelli D; Montesarchio V; De Lorenzo F; Del Campo L; Iannelli E; Traclò F; Gitto L; Jommi C; Vaccaro CM; Gimigliano A; Sparavigna L; Perrone F;
Long-term toxicity profile of trastuzumab emtansine (T-DM1): A multicenter real-life study in Journal of Clinical Oncology
2019
AO Ordine Mauriziano
Buono G; Fabi A; Del Mastro L; Cannita K; La Verde NM; Ardito R; Riccardi F; Montemurro F; Cazzaniga ME; Garrone O; Zambelli A; Conte B; Caputo R; Cianniello D; Bonotto M; Bartoletti M; Parola S; De Placido S; Di Maio M; Arpino G;
Prognostic score for second or further line immunotherapy in advanced non-small cell lung cancer (aNSCLC): An external validation in Journal of Clinical Oncology
2019
AO Ordine Mauriziano
Prelaj A; Russo GL; Proto C; Signorelli D; Ferrara R; Galli G; De Toma A; Randon G; Zilembo N; Trevisan B; Montrone M; Longo V; Pesola F; Varesano N; Del Bene G; Pizzutilo P; Galetta D; Garassino MC; Di Maio M; Catino A;
Host metabolic factors and prognosis in patients treated with immune checkpoint inhibitors for advanced malignancies in Journal of Clinical Oncology
2019
AO Ordine Mauriziano
Biello F; Audisio M; Genestroni S; Borra G; D'Avanzo F; Lacidogna G; Sponghini AP; Rondonotti D; Forti L; Vignani F; Adesi FB; Di Maio M; Sica A; Gennari A;
Chemotherapy in combination with immune checkpoint inhibitors for the first-line treatment of patients with advanced non-small cell lung cancer: A systematic review and literature-based metaanalysis in Journal of Clinical Oncology
2019
AO Ordine Mauriziano
Addeo A; Banna GL; Metro G; Di Maio M;
Quality-of-life (QoL) assessment and reporting in prostate cancer: A systematic review of phase III trials published between 2012 and 2016 in Journal of Clinical Oncology
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; ButtIgliero C; Tucci M; Aglietta M; Scagliotti GV; Perrone F; Di Maio M;
CK7 and consensus molecular subtypes as major prognosticators in V600E BRAF mutated metastatic colorectal cancer in British Journal of Cancer
2019
AO Ordine Mauriziano
Zagonel V; Di Maio M; Fassan M; Mescoli C; Lonardi S; Rugge M; Munari G; Salmaso R; Guzzardo V; Salvatore L; Santini D; Smiroldo V; Calvetti L; Aprile G; De Maglio G; Rimassa L; Morano F; Cortiula F; Schirripa M; Bergamo F; Antoniotti C; Zichi C; Intini R; Dadduzio V; Pella N; Dell’Aquila E; Sperti E; Prete AA; Cremolini C; et alii...
Description of adverse events in publications of clinical trials: Much room for improvement in Recenti Progressi in Medicina
2019
AO Ordine Mauriziano
Antonuzzo A; Bossi P; Di Maio M;
Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer? in Translational lung cancer research / Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S294-S296. doi: 10.21037/tlcr.2018.07.12.
2018
AO Ordine Mauriziano
Metro G; Di Maio M;
Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer? in Translational lung cancer research / Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S290-S293. doi: 10.21037/tlcr.2018.07.11.
2018
AO Ordine Mauriziano
Metro G; Di Maio M;
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Sep;129:54-66. doi: 10.1016/j.critrevonc.2018.06.011. Epub 2018 Jun 21.
2018
AO Ordine Mauriziano
Trestini I; Carbognin L; Monteverdi S; Zanelli S; De Toma A; Bonaiuto C; Nortilli R; Fiorio E; Pilotto S; Di Maio M; Gasbarrini A; Scambia G; Tortora G; Bria E;
Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences. in Cancer treatment reviews / Cancer Treat Rev. 2018 Sep;69:215-223. doi: 10.1016/j.ctrv.2018.07.010. Epub 2018 Jul 20.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Di Maio M; Scagliotti GV; Ricardi U; Ruo Redda MG; Di Stefano RF; Leone G; Zichi C; Tucci M; Allis S; Buttigliero C; Filippi AR;
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. in Immunotherapy / Immunotherapy. 2018 Oct;10(14):1229-1239. doi: 10.2217/imt-2018-0080.
2018
AO Ordine Mauriziano
Bersanelli M; Giannarelli D; Castrignanò P; Fornarini G; Panni S; Mazzoni F; Tiseo M; Rossetti S; Gambale E; Rossi E; Papa A; Cortellini A; Lolli C; Ratta R; Michiara M; Milella M; De Luca E; Sorarù M; Mucciarini C; Atzori F; Banna GL; La Torre L; Vitale MG; Massari F; Rebuzzi SE; Facchini G; Schinzari G; Tomao S; Bui S; et alii...
[Influenza vaccination in advanced cancer patients undergoing immunotherapy with anti-PD-1/PD-L1 immune checkpoint inhibitors: what data do we have for the clinical recommendation?]. in Recenti progressi in medicina / Recenti Prog Med. 2018 Nov;109(11):540-546. doi: 10.1701/3031.30291.
2018
AO Ordine Mauriziano
Bersanelli M; Buti S; De Giorgi U; Di Maio M; Giannarelli D; Banna GL;
Loss of C/EBP-? LIP drives cisplatin resistance in malignant pleural mesothelioma. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2018 Jun;120:34-45. doi: 10.1016/j.lungcan.2018.03.022. Epub 2018 Mar 26.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Rubinstein M; Novello S; Di Maio M; Napoli F; Pradotto M; Capelletto E; Ricci L; Ananthanarayanan P; Milosevic V; Grosso F; Libener R; Orecchia S; Salaroglio IC; Righi L; Kopecka J; Scagliotti GV; Riganti C;
Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study. in Clinical lung cancer / Clin Lung Cancer. 2018 Jan;19(1):93-104. doi: 10.1016/j.cllc.2017.05.016. Epub 2017 Jun 1.
2018
AO Ordine Mauriziano
AOU Alessandria
Barbieri F; Rizzo E; Menis J; Filipazzi V; Mucciarini C; Genestreti G; Bearz A; Barzelloni ML; Ardizzoia A; Banna GL; Casartelli C; Zilembo N; Cortinovis D; Piovano PL; Caffo O; Martelli O; Di Maio M; Morabito A; Tiseo M; Galetta D; Rijavec E; Cecere F; Spitaleri G; Bria E; Novello S; Follador A; Vavalà T; Rossi A; Pilotto S; et alii...
Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression. in Oncotarget / Oncotarget. 2018 Jan 3;9(11):9661-9671. doi: 10.18632/oncotarget.23800. eCollection 2018 Feb 9.
2018
AO Ordine Mauriziano
Trombetta D; Graziano P; Scarpa A; Sparaneo A; Rossi G; Rossi A; Di Maio M; Antonello D; Mafficini A; Fabrizio FP; Manzorra MC; Balsamo T; Centra F; Simbolo M; Pantalone A; Notarangelo M; Parente P; Lucia Dimitri MC; Bonfitto A; Fiordelisi F; Storlazzi CT; L'Abbate A; Taurchini M; Maiello E; Fazio VM; Muscarella LA;
A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Feb;122:21-29. doi: 10.1016/j.critrevonc.2017.12.010. Epub 2017 Dec 16.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Baratelli C; Zichi C; Di Maio M; Brizzi MP; Sonetto C; Scagliotti GV; Tampellini M;
Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide. in Clinical and translational radiation oncology / Clin Transl Radiat Oncol. 2018 Aug 13;12:47-52. doi: 10.1016/j.ctro.2018.08.001. eCollection 2018 Au
2018
AO Ordine Mauriziano
AO Cuneo
Corvò R; Russi EG; Vecchio S; Curcio P; Fruttero C; Galizia D; Di Maio M; Denaro N; Fea E; Licitra L; Merlano MC; Merlotti AM;
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. in Gastroenterology / Gastroenterology. 2018 Aug;155(2):479-489.e7. doi: 10.1053/j.gastro.2018.04.010. Epub 2018 Apr 13.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Cuneo
Mazzaferro V; Delle Fave G; Buzzoni R; Giacomelli L; Milione M; Lo Russo G; Prinzi N; Concas L; Femia D; Tafuto S; Garattini SK; Di Costanzo F; Torniai M; Bajetta E; Ortolani S; Zaniboni A; Puliafito I; Panzuto F; Brighi N; Colao A; La Salvia A; Bongiovanni A; Ricci S; Fazio N; Cavalcoli F; Cauchi C; Duro M; Carnaghi C; Davì MV; et alii...
Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Apr;124:21-28. doi: 10.1016/j.critrevonc.2018.02.001. Epub 2018 Feb 7.
2018
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Di Maio M; Baratelli C; Bironzo P; Vignani F; Bria E; Sperti E; Marcato M; Roila F;
Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM). in ESMO open / ESMO Open. 2018 Oct 21;3(6):e000389. doi: 10.1136/esmoopen-2018-000389. eCollection 2018.
2018
AO Ordine Mauriziano
Dieci MV; Massari F; Giusti R; Inno A; Lombardi G; Noto L; Passaro A; Pietrantonio F; Spada F; Valente M; Di Maio M; Torri V;
Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions. in OncoTargets and therapy / Onco Targets Ther. 2018 Oct 24;11:7353-7368. doi: 10.2147/OTT.S153764. eCollection 2018.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Tucci M; Zichi C; Buttigliero C; Vignani F; Scagliotti GV; Di Maio M;
Moving from the CLEOPATRA study to real life: Results from the G.O.N.O. SUPER trial in Journal of Clinical Oncology
2018
ASL Asti
AOU Città della Salute di Torino
AO Ordine Mauriziano
Garrone O; Giarratano T; Saggia C; Bertolini I; Beano A; Blondeaux E; Riva F; D'Onofrio L; Merlini L; Coltelli L; La Verde NM; Vandone AM; Milani A; Collovà E; Ardito R; Airoldi M; De Conciliis E; Blasi L; Di Maio M; Merlano MC;
2018
AO Ordine Mauriziano
Lambertini M; Di Maio M; Pagani O; Curigliano G; Poggio F; Del Mastro L; Paluch-Shimon S; Loibl S; Partridge AH; Demeestere I; Azim HA; Peccatori FA;
Biases in assessment and reporting of health-related quality of life (QoL): A systematic review of oncology randomized phase III trials published between 2012 and 2016 in Journal of Clinical Oncology
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; Marcato M; Bironzo P; Aglietta M; Scagliotti GV; Perrone F; Di Maio M;
Bevacizumab (B) + bi-weekly capecitabine (C) and oxaliplatin (O) (XELOX2) or FOLFOX4 in first-line treatment of metastatic colorectal cancer (mCRC): Final results of a multicenter randomized phase II trial of the Gruppo Oncologico dell'Italia Meridionale (GOIM protocol 2802) in Journal of Clinical Oncology
2018
AO Ordine Mauriziano
Maiello E; Di Maggio G; Cordio SS; Cinieri S; Giuliani F; Pisconti S; Rinaldi A; Febbraro A; Pia Latiano T; Aieta M; Rizzi D; Di Maio M; Colucci G; Bordonaro R;
2018
AO Ordine Mauriziano
Bazan V; Russo A; Passiglia F; Rizzo S; Di Maio M; Galvano A; Badalamenti G; Listì A; Gulotta L; Castiglia M; Fulfaro F;
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis in Scientific reports
2018
AO Ordine Mauriziano
Passiglia F; Rizzo S; Di Maio M; Galvano A; Badalamenti G; Listì A; Gulotta L; Castiglia M; Fulfaro F; Bazan V; Russo A;
Selection of Non-small Cell Lung Cancer Patients for Intercalated Chemotherapy and Tyrosine Kinase Inhibitors. in Radiology and oncology / Radiol Oncol. 2017 Jul 18;51(3):241-251. doi: 10.1515/raon-2017-0029. eCollection 2017 Sep.
2017
AO Ordine Mauriziano
Zwitter M; Rossi A; Di Maio M; Perme MP; Lopes G;
Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2017 Sep;111:30-37. doi: 10.1016/j.lungcan.2017.06.009. Epub 2017 Jun 16.
2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AO Ordine Mauriziano
Novello S; Bordi P; Catino A; Pisconti S; Cortinovis D; Franchina T; Migliorino MR; Delmonte A; Buffoni L; Ceribelli A; Scotti V; Riccardi F; Gregorc V; Di Maio M; Rossi G; Bria E; Rossi A; Graziano P; Tiseo M; Galetta D; Gobbini E; Maiello E; Arizio F;
Outcomes research: Integrating PROs into the clinic - overall survival benefit or not, it's worth the trouble. in Nature reviews. Clinical oncology / Nat Rev Clin Oncol. 2017 Sep;14(9):529-530. doi: 10.1038/nrclinonc.2017.109. Epub 2017 Jul 18.
2017
AO Ordine Mauriziano
Sperti E; Di Maio M;
Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer. in Expert review of respiratory medicine / Expert Rev Respir Med. 2017 Mar;11(3):171-180. doi: 10.1080/17476348.2017.1290526. Epub 2017 Feb 9.
2017
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Rossi A; La Salvia A; Di Maio M;
A Case Where Switching the End Points for Clinical Trial Interpretation Might Be the Right Choice. in JAMA oncology / JAMA Oncol. 2017 Jun 1;3(6):735-736. doi: 10.1001/jamaoncol.2016.4896.
2017
AO Ordine Mauriziano
Perrone F; Di Maio M; Del Mastro L;
[Let's go forward, but wisely…]. in Recenti progressi in medicina / Recenti Prog Med. 2017 Dec;108(12):494-496. doi: 10.1701/2829.28578.
2017
AO Ordine Mauriziano
Di Maio M;
Can intercalating chemotherapy with epidermal growth factor receptor inhibitors delay development of treatment resistance in advanced non-small cell lung cancer? in Expert opinion on pharmacotherapy / Expert Opin Pharmacother. 2017 Dec;18(18):1899-1902. doi: 10.1080/14656566.2017.1409721. Epub 2017 N
2017
AOU San Luigi di Orbassano
AO Ordine Mauriziano
La Salvia A; De Luca E; Rossi A; Di Maio M;
Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives. in BioMed research international / Biomed Res Int. 2017;2017:5618174. doi: 10.1155/2017/5618174. Epub 2017 Jun 7.
2017
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Di Maio M; Scagliotti GV; Pignataro D; Vignani F; Buttigliero C; Leone G; Tucci M; Zichi C;
2017
ASL Biella
AO Ordine Mauriziano
Ruzzo A; Galli F; Rulli E; Lonardi S; Zagonel V; Ronzoni M; Ionta MT; Pella N; Mucciarini C; Labianca R; Veltri E; Sozzi P; Barni S; Nicolini M; Biondi E; Bramati A; Turci D; Buscaglia M; Magnani M; Graziano F; Tampellini M; Falco E; De Rosa G; Montarolo F; Dacomo R; Baratelli C; Sperti E; Di Maio M; Scagliotti GV; et alii...
2017
AO Ordine Mauriziano
AOU Alessandria
Fusco V; Cabras M; Gambino A; Bertetto O; Numico G; De Martino I; Alessio M; Marinella M; Di Maio M; Baratelli C; Bironzo P; Vignani F; Bria E; Sperti E; Marcato M; Roila F;
Surrogate endpoints in second-line trials of targeted agents in metastatic colorectal cancer: A literature-based systematic review and meta-analysis in Cancer Research and Treatment
2017
AO Ordine Mauriziano
Falcone A; Di Maio M; Loupakis F; de Braud F; Di Bartolomeo M; Sonetto C; Bironzo P; Nichetti F; Borelli B; Marmorino F; Salvatore L; Baratelli C; Tampellini M; Berenato R; Pietrantonio F; Antoniotti C; Cremolini C;
Dissecting primary resistance to anti-EGFR monoclonal antibodies (anti-EGFRs) in RAS and BRAF wild-type (wt) metastatic colorectal cancer (mCRC) in Cancer Research
2017
AO Ordine Mauriziano
Pietrantonio F; Falcone A; De Braud F; Fontanini G; Di Maio M; Milione M; Volpi CC; Capone I; Tamburini E; Baratelli C; Fucà G; Busico A; Gloghini A; Rossini D; Tamborini E; Perrone F; Moretto R; Morano F; Berenato R; Cremolini C;
2017
AO Ordine Mauriziano
Pusceddu S; Vernieri C; Di Maio M; Daniela F; Prinzi N; Marconcini R; Spada F; Massironi S; Bongiovanni A; Brizzi MP; Campana D; Faggiano A; Giuffrida D; Delle Fave G; Cingarlini S; Aroldi F; Antonuzzo L; Berardi R; Catena L; Buzzoni R; De Braud F;
Correlation of pd-l1 staining in tumor cells and tumor infiltrate between primary tumors and matched metastasis in advanced colorectal cancer patients in Annals of Oncology
2017
AO Ordine Mauriziano
Tampellini M; Falco E; De Rosa G; Montarolo F; Dacomo R; Baratelli C; Sperti E; Di Maio M; Scagliotti Giorgio V; Volante M;
Lessons from clinical trials on quality-of-life assessment in ovarian cancer trials. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 Jun;27(6):961-962. doi: 10.1093/annonc/mdw153. Epub 2016 Apr 7.
2016
AO Ordine Mauriziano
Di Maio M; Perrone F;
Ethics in oncology: principles and responsibilities declared in the Italian Ragusa statement. in Tumori / Tumori. 2016 Dec 1;102(6):e25-e27. doi: 10.5301/tj.5000582.
2016
AO Ordine Mauriziano
AO Cuneo
Bordonaro R; Labianca R; Micallo G; Fioretto L; Zagonel V; Merlano M; Passalacqua R; Crispino S; Di Costanzo F; De Cicco M; Mancuso A; Omodeo Salè E; Di Maio M; Perrone F; Nicolis F; Iacono C; Spinsanti S; Comandone A; Marchetti P; Aprile G; Caminiti C; Pinto C; Gori S;
Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM). in ESMO open / ESMO Open. 2016 Dec 12;1(6):e000109. doi: 10.1136/esmoopen-2016-000109. eCollection 2016.
2016
AO Ordine Mauriziano
Di Maio M; Bruzzi P; Perrone F; Torri V; Montemurro F; Tiseo M; Vasile E;
Measuring the Real Clinical Impact of Randomized Clinical Trials in Oncology: Beyond Citation Counts in JAMA oncology
2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Di Maio M; Baratelli C; Tampellini M;
Systematic review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy in Annals of Oncology
2016
AO Ordine Mauriziano
Bossi P; Botta L; Bironzo P; Sonetto C; Musettini G; Sbrana A; Di Giannantonio V; Locati L; Di Maio M; Antonuzzo A;
MET exon 14 mutation: Another actionable genomic variation in patients with advanced NSCLC in Translational Cancer Research
2016
AO Ordine Mauriziano
Di Maio M; Bironzo P; Scagliotti GV;
Systematic review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy in Annals of Oncology
2016
AO Ordine Mauriziano
Bossi P; Botta L; Bironzo P; Sonetto C; Musettini G; Sbrana A; Di Giannantonio V; Locati L; Di Maio M; Antonuzzo A;